<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/96EFA8D6-9087-45CB-B5F1-FFAFE8D3BE64"><gtr:id>96EFA8D6-9087-45CB-B5F1-FFAFE8D3BE64</gtr:id><gtr:name>Sangamo Biosciences, Inc</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/96EFA8D6-9087-45CB-B5F1-FFAFE8D3BE64"><gtr:id>96EFA8D6-9087-45CB-B5F1-FFAFE8D3BE64</gtr:id><gtr:name>Sangamo Biosciences, Inc</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/224957BB-8412-488A-984C-F3BBF8A90244"><gtr:id>224957BB-8412-488A-984C-F3BBF8A90244</gtr:id><gtr:firstName>Aaron</gtr:firstName><gtr:surname>Klug</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U105184324"><gtr:id>2DA9591A-A397-48FE-A1F4-B81247846F36</gtr:id><gtr:title>Engineered zinc finger proteins for the regulation of gene expression</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U105184324</gtr:grantReference><gtr:abstractText>Many biological processes are determined by the switching on or off of the genes which code for the proteins involved in the processes. This regulation of gene expression is controlled by regulatory proteins called transcription factors. We are engineering artificial transcription factors based on a naturally occurring design, the zinc finger motif, which uniquely lends itself to the production of factors. These can recognise sequences of DNA selectively, and so target a desired gene without activating or repressing other genes. Clinical trials are now in progress for stimulating the growth of new arteries in patients suffering from obstruction of the blood vessels in the limbs. This is a powerful technology for intervening in gene expression in health or disease and therapeutic applications are planned for other diseases e.g. knocking out the receptor of HIV in Tcells of AIDS patients, so leading to a supply of non-infectable Tcells, which will combat HIV and also the adventitious infections which occur in AIDS patients.</gtr:abstractText><gtr:technicalSummary>1 General Aims Relevance Health Issues The aims of the project are to develop zinc finger peptides to intervene in gene expression with potential applications in research and therapy for various genetic malfunctions and diseases. 2 Precise Scientific Objectives Zinc fingers are small DNA binding peptide motifs that I discovered in this Laboratory. These motifs can be used as modular building blocks for the construction of larger protein domains that recognize and bind to specific DNA sequences. Phage display has been used to create a large library of different zinc fingers from which selections were made for binding to a given DNA sequence. From this database there have been elucidated elements of recognition rules that relate the amino acid sequence of a finger to its preferred DNA binding site. Control of gene expression using designed zinc finger peptides has been demonstrated by the specific inhibition of an oncogene mouse cell line and also by switching on genes in expression plasmids. These experiments demonstrate that zinc-finger DNA binding domains can be engineered de novo to recognize given DNA sequences. Five to six individual zinc fingers linked together would recognize a DNA sequence 15-18 basepairs in length, sufficiently long to constitute a rare address in the human genome. By adding functional groups to the engineered DNA binding domains, e.g. silencing domains, novel transcription factors can be generated to up- or downregulate expression of a target gene. Among research applications are the repression of oncogene expression and the disruption of the infective cycle of virus infection. 3 Plan of Investigation The technical side of our work involved making DNA constructs, transfecting cells and reporter gene readout, protein expression, measuring DNA and RNA affinities for zinc fingers. 4 Subsequent Scientific/Medical Opportunities Has potential application in gene therapy. A spin-off company, Gendaq, which was formed by the MRC in 1999, was acquired in 2005 by a US Company, Sangamo Biosciences Inc, together with licences to the MRC Patents. They have begun clinical trials for various human deficiencies or diseases, including peripheral obstructive arterial disease (PAD), diabetic neuropathy (DN); and gene correction in monogenic disease has now been developed. Phase 1b trials for PAD, and phase 2 for DN, have recently been unblinded and show dramatic improvements. 5 Key Words: Zinc finger, gene expression, DNA constructs, therapeutic applications</gtr:technicalSummary><gtr:fund><gtr:end>2008-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1995-01-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>158382</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sangamo Biosciences, Inc</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Engineered zinc finger proteins for the regulation of gene expression</gtr:description><gtr:id>F64C9377-AAE5-443C-8011-49183581E610</gtr:id><gtr:impact>Sangamo has been granted the go ahead for clinical trials on the use of a zinc finger construct as a therapeutic agent to stimulate blood vessel growth in human peripheral vascular disease.</gtr:impact><gtr:outcomeId>0536F3B3481-1</gtr:outcomeId><gtr:piContribution>The aims of the project are to develop zinc finger peptides to intervene in gene expression with potential applications in research and therapy for various genetic malfunctions and diseases.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Dawn of the new drugs that treat illness by aiming at a single gene</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>DA7BDA43-D0EA-4C33-84F5-93DAED91835F</gtr:id><gtr:impact>Press Article in The Times

Not known</gtr:impact><gtr:outcomeId>50944AC8ABF</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC News online Gene targeting raises cure hopes</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>BC433C3D-C7C0-4B01-AD66-14B34BD2F012</gtr:id><gtr:impact>BBC News online Gene targeting raises cure hopes

Not known</gtr:impact><gtr:outcomeId>593731DA965</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>New research at last gives gene therapy the chance to fulfil its potential</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>664CEF5D-E126-49B2-9612-8487DE03A9E0</gtr:id><gtr:impact>Article in Telegraph written by Roger Highfield

Not known</gtr:impact><gtr:outcomeId>F52EAEE5454</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Gene surgery trials offer hope for diabetics and aids sufferers</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>5CA9BDD0-21EC-4BAC-B6CA-6D0F238876E9</gtr:id><gtr:impact>Press Article in Daily Telegraph

Not known</gtr:impact><gtr:outcomeId>822B9F9106F</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Writers join scientists for creative conversation</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>15FD4C7D-48B0-4A89-A416-87761E5946BC</gtr:id><gtr:impact>PEN creative energy event

Not known</gtr:impact><gtr:outcomeId>727E916F66D</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>AEF735DF-4400-41A3-BBA9-0337B68D5041</gtr:id><gtr:title>The discovery of zinc fingers and their applications in gene regulation and genome manipulation.</gtr:title><gtr:parentPublicationTitle>Annual review of biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d67d900e39e674cef957aae0def0338"><gtr:id>6d67d900e39e674cef957aae0def0338</gtr:id><gtr:otherNames>Klug A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0066-4154</gtr:issn><gtr:outcomeId>aHeuZcXf9Ga</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>138CABD9-FF33-4963-8407-70EC109D3F4A</gtr:id><gtr:title>Development of a single-chain, quasi-dimeric zinc-finger nuclease for the selective degradation of mutated human mitochondrial DNA.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d383d560f7c020e3b3e59a36dd85c29c"><gtr:id>d383d560f7c020e3b3e59a36dd85c29c</gtr:id><gtr:otherNames>Minczuk M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>409D9145C4B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD0B7023-860E-4BE8-BA63-2082D2A60632</gtr:id><gtr:title>The discovery of zinc fingers and their development for practical applications in gene regulation and genome manipulation.</gtr:title><gtr:parentPublicationTitle>Quarterly reviews of biophysics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d67d900e39e674cef957aae0def0338"><gtr:id>6d67d900e39e674cef957aae0def0338</gtr:id><gtr:otherNames>Klug A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0033-5835</gtr:issn><gtr:outcomeId>p3SaTzeZs3u</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E581A7EA-AC09-44BA-A967-91CF94257B11</gtr:id><gtr:title>The Alzheimer tangle - 100 years on</gtr:title><gtr:parentPublicationTitle>Alzheimer: 100 Years and Beyond (Ed: Jucker et al)  Spinger-Verlag, 2006</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/43b6bad45d1a92ce948b67ce127f1619"><gtr:id>43b6bad45d1a92ce948b67ce127f1619</gtr:id><gtr:otherNames>Michel Goedert, Maria Grazia Spillantini, Bernardino Ghetti, R.Anthony Crowther, Aaron Klug</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:outcomeId>B511AE749E5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7271E4C3-BEF2-42C1-8487-6CD1E1828398</gtr:id><gtr:title>Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24a8e53daa9ae3dc27876ebc78dd602f"><gtr:id>24a8e53daa9ae3dc27876ebc78dd602f</gtr:id><gtr:otherNames>Santiago Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>E1E3BF4F376</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9283B51-02AC-4418-A339-56C0C39A14BC</gtr:id><gtr:title>A rapid, generally applicable method to engineer zinc fingers illustrated by targeting the HIV-1 promoter.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/059687c80a17c5d773d0a4dba2dcdbf8"><gtr:id>059687c80a17c5d773d0a4dba2dcdbf8</gtr:id><gtr:otherNames>Isalan M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2001-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>pm_540e180e1807875c4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D42F766D-F9C3-4310-B563-45E7D9A94E5A</gtr:id><gtr:title>Sequence-specific modification of mitochondrial DNA using a chimeric zinc finger methylase.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d383d560f7c020e3b3e59a36dd85c29c"><gtr:id>d383d560f7c020e3b3e59a36dd85c29c</gtr:id><gtr:otherNames>Minczuk M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>C5850717948</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ECC97C15-D76B-4AF9-933E-3F491F5C7D12</gtr:id><gtr:title>From virus structure to chromatin: X-ray diffraction to three-dimensional electron microscopy.</gtr:title><gtr:parentPublicationTitle>Annual review of biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d67d900e39e674cef957aae0def0338"><gtr:id>6d67d900e39e674cef957aae0def0338</gtr:id><gtr:otherNames>Klug A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0066-4154</gtr:issn><gtr:outcomeId>tjzuptXeyHj</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U105184324</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>